Michael Laule Selected Research

contrast agent P792

4/2007	Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
4/2004	Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Laule Research Topics

Disease

11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2002
9	Myocardial Infarction 11/2021 - 04/2004
5	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022 - 05/2013
5	Heart Failure 04/2020 - 12/2002
5	Pathologic Constriction (Stenosis) 01/2018 - 02/2006
5	Infarction (Infarctions) 06/2009 - 04/2004
4	Hypertension (High Blood Pressure) 01/2016 - 08/2003
4	Fibrosis (Cirrhosis) 01/2016 - 09/2002
3	Chest Pain (Chest Pains) 01/2019 - 06/2012
3	Aortic Valve Stenosis (Aortic Stenosis) 02/2017 - 03/2012
2	Stroke (Strokes) 11/2021 - 07/2017
2	Pain (Aches) 01/2015 - 08/2011
2	Hemorrhage 07/2013 - 08/2004
2	Neointima 02/2006 - 01/2002
1	Body Weight (Weight, Body) 11/2021
1	Hyperemia 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Heart Valve Diseases (Valvular Heart Disease) 01/2018
1	Pulmonary Hypertension 01/2017
1	Death (Near-Death Experience) 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Aortic Arch Aneurysm 06/2016
1	Inflammation (Inflammations) 01/2016
1	Carcinoid Heart Disease 01/2016
1	Dyspnea (Shortness of Breath) 01/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 05/2014
1	Atrioventricular Block 07/2013
1	Ventricular Remodeling 09/2012
1	Chronic Limb-Threatening Ischemia 08/2011
1	Thromboangiitis Obliterans (Buerger's Disease) 08/2011
1	Phobic Disorders (Phobia) 05/2006
1	Atherosclerosis 11/2004
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 08/2004
1	Pulmonary Embolism 08/2004
1	Hyperhomocysteinemia 05/2003
1	Acute Coronary Syndrome 05/2003
1	Thrombosis (Thrombus) 09/2002
1	Hyperplasia 01/2002

Drug/Important Bio-Agent (IBA)

5	Cytidine Triphosphate (CTP)IBA 01/2022 - 10/2013
3	omega-Chloroacetophenone (Mace)IBA 11/2021 - 01/2017
3	Contrast MediaIBA 01/2019 - 04/2004
3	triphenyltetrazoliumIBA 06/2009 - 06/2006
2	pro-brain natriuretic peptide (1-76)IBA 04/2020 - 02/2017
2	Galectin 3 (LGALS3)IBA 01/2016 - 12/2014
2	contrast agent P792IBA 04/2007 - 04/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2004 - 01/2002
2	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 10/2004 - 01/2002
2	Proteasome InhibitorsIBA 10/2004 - 01/2002
2	Tenecteplase FDA Link 08/2004 - 08/2004
2	Endothelin-1 (Endothelin 1)IBA 08/2003 - 01/2003
1	DiureticsIBA 11/2021
1	AdrenomedullinIBA 02/2017
1	Atrial Natriuretic Factor (ANF)IBA 02/2017
1	Natriuretic PeptidesIBA 02/2017
1	AldosteroneIBA 01/2016
1	Heparin (Liquaemin)FDA LinkGeneric 07/2013
1	CalciumIBA 06/2012
1	Carbon DioxideIBA 08/2011
1	Oxygen (Dioxygen)IBA 08/2011
1	Troleandomycin (TAO)FDA Link 08/2011
1	DiamondIBA 06/2011
1	TungstenIBA 06/2009
1	Endothelins (Endothelin)IBA 01/2007
1	Endothelin-Converting EnzymesIBA 01/2007
1	A-factor (Streptomyces)IBA 06/2006
1	Sirolimus (Rapamycin)FDA Link 02/2006
1	PolymersIBA 02/2006
1	AntioxidantsIBA 11/2004
1	CollagenIBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 10/2004
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 04/2004
1	gadoterate meglumineIBA 04/2004
1	Adenine FDA LinkGeneric 08/2003
1	Messenger RNA (mRNA)IBA 08/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2003
1	HomocysteineIBA 05/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2003
1	Vasoconstrictor AgentsIBA 01/2003
1	RelaxinIBA 01/2003
1	urotensin IIIBA 12/2002
1	UbiquitinIBA 01/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2002
6	Transcatheter Aortic Valve Replacement 02/2017 - 03/2012
3	Catheters 01/2022 - 06/2012
3	Stents 06/2016 - 02/2006
2	Sympathectomy (Sympathectomies) 01/2016 - 06/2014
1	Prostheses and Implants (Prosthesis) 01/2018
1	Bioprosthesis 05/2013
1	Ligation 06/2009
1	Thoracotomy 06/2009
1	Contraindications 05/2006
1	Thrombolytic Therapy 08/2004
1	Brachytherapy 09/2002